Galena Biopharma (GALE) Misses Q1 Loss Views

Galena Biopharma (NASDAQ: GALE) reported Q1 EPS of ($0.52), $0.42 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Bank of America to acquire up to 49.9% stake in Jio Credit for ~$1.9B
• NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark